Showing results (161-170 of 3,377) with videos related to

Sort By:
Pageof 338
Eclinicalmedicine|July 26, 2021
Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analysesManasi Agrawal, João Sabino, Catarina Frias-Gomes, et al.
Eclinicalmedicine|July 26, 2021
Cardiovascular toxicities associated with abiraterone compared to enzalutamide-A pharmacovigilance studyEugene B Cone, Stephen Reese, Maya Marchese, et al.
Eclinicalmedicine|July 26, 2021
The influence of modifiable risk factors on short-term postoperative outcomes following cervical spine surgery: A retrospective propensity score matched analysisShane Shahrestani, Joshua Bakhsheshian, Xiao T Chen, et al.
Eclinicalmedicine|July 26, 2021
N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trialRebecca McKetin, Olivia M Dean, Alyna Turner, et al.
Eclinicalmedicine|July 26, 2021
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in IndiaTaufik Momin, Kevinkumar Kansagra, Hardik Patel, et al.
Eclinicalmedicine|July 5, 2021
Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological studyMary K Foley, Samuel D Searle, Ali Toloue, et al.
Eclinicalmedicine|July 5, 2021
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation studySzu-Min Hsieh, Wang-Da Liu, Yu-Shan Huang, et al.
Eclinicalmedicine|July 1, 2021
Impact of 1% chlorhexidine gluconate bathing and emollient application on bacterial pathogen colonization dynamics in hospitalized preterm neonates - A pilot clinical trialAngela Dramowski, Sheylyn Pillay, Adrie Bekker, et al.
Eclinicalmedicine|July 1, 2021
Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohortLéo Plaçais, Faroudy Boufassa, Camille Lécuroux, et al.
Eclinicalmedicine|July 1, 2021
Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial dataNicholas Swart, Roberta Maroni, Beth Muldrew, et al.
Pageof 338